Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

J. Schetelig*, L. C. de Wreede, M. van Gelder, N. S. Andersen, C. Moreno, A. Vitek, M. Karas, M. Michallet, M. Machaczka, M. Gramatzki, D. Beelen, J. Finke, J. Delgado, L. Volin, J. Passweg, P. Dreger, A. Henseler, A. van Biezen, M. Bornhaeuser, S. O. SchoenlandN. Kroeger, CLL Subcomm, Chronic Malignancies Working Party

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)552-560
Number of pages9
JournalBone Marrow Transplantation
Volume52
Issue number4
DOIs
Publication statusPublished - Apr 2017

Keywords

  • CHRONIC LYMPHOCYTIC-LEUKEMIA
  • STEM-CELL TRANSPLANTATION
  • RETROSPECTIVE ANALYSIS
  • FOLLOW-UP
  • IBRUTINIB
  • SURVIVAL
  • DISEASE
  • VENETOCLAX
  • MECHANISMS
  • IDELALISIB

Cite this